HBOT Conversations:
Dr. Paul Harch & Birth Injuries/ Cerebral Palsy
Dr. Paul G. Harch, M.D. has used hyperbaric oxygen therapy to treat more than 100 different conditions, including stroke, dementia, autism, and traumatic brain injury. His goal is to help his patients get their lives back using hyperbaric oxygen therapy.
He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.
This episode on birth injuries with a strong focus on Cerebral Palsy (CP) is the fifth in a nine episode series that will be released weekly with Dr. Harch.
Watch the Podcast
In episode 5 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch about birth injuries and Cerebral Palsy (Chapter 5 of his book, The Oxygen Revolution).
In Dr. Harch’s book he describes the trip down the birth canal as one of the most high-risk journeys any human will ever make. Dr. Harch educates us on how traumatic birth experiences can trigger Cerebral Palsy diagnoses in young infants, and how premature babies are at great risk for Cerebral Palsy since they are born with the center of the brain undeveloped, still very fragile and prone to spontaneous bleeding.
Every day desperate parents around the world seek alternative healing therapies for their children with cerebral palsy. Dr. Harch dives deep into the use of Hyperbaric Oxygen Therapy (HBOT) for the treatment of Cerebral Palsy and other neurological birth disorders, and explains the reasons why parents should embrace this therapy. Essentially, Dr. Harch describes Cerebral Palsy as a wound to the brain, so it should respond to Hyperbaric Oxygen Therapy the same way as other brain injuries. He confers that it absolutely does.
Dr. Harch reveals success stories of CP children who have had found hope and new life from Hyperbarics. In response to these stories and hearing that it works to heal and ease life-long debilitating CP symptoms, di Girolamo wants to know why more parents aren’t seeking out HBOT to help their cerebral palsy children? Harch relays that there’s too much inconsistent medical literature out there, and in many ways it’s just plain wrong. For example, a parent asks their doctor, “How about HBOT to treat Cerebral Palsy?”— the doctor might be unfamiliar with the therapy, so he/she checks the online medical database for HBOT and CP. Unfortunately this doctor will likely find some skewed data, leading the doctor to respond with “so….. I don’t think it’ll help”. Although, as Dr. Harch explains, the exact opposite is what’s true; HBOT absolutely helps CP patients.
One example given is that a well respected peer-reviewed medical journal, The Lancet, published medical literature on HBOT and CP announcing there was no proven benefit to use Hyperbaric Oxygen Therapy to treat Cerebral Palsy. But, the inconsistency there was that the control group was defined as a placebo, and that was not right. In response, Dr. Pierre Marois and his team, released a retrospective study on HBOT in the treatment of Cerebral Palsy that showed studies and numerous reports demonstrating the positive effects of Hyperbaric Oxygen Therapy (HBOT) in children with Cerebral Palsy.
Dr. Harch suggests our viewers dive into his 2021 presentation at the Team Luke3 Hope for Minds pediatric brain injury conference. Dr. Harch provided a summarization of all of the science showing that Hyperbaric Oxygen Therapy had extremely positive effects on every stage of the stem cell process. Additionally, Dr. Proefrock’s presentation from the same conference, “Current Trends in Naturopathic Treatment of Pediatric Neurological Injury” reveals stem cell data for children in the midst of HBOT treatment; showing that the children who have had Hyperbaric treatments produced 4x the amount of stem cells compared to those who did not.
Dr. Harch explains the roadblock for using Hyperbaric Oxygen for treatment of CP is still extremely difficult to get around, and he references the 2012 article by Novak and Badawai, Last breath: effectiveness of hyperbaric oxygen treatment for Cerebral Palsy as an example. In this article, they concluded that “Hyperbaric Oxygen does not have a clinically important effect on gross motor and self-care function in children with Cerebral Palsy.” Dr. Harch clarifies why they were wrong on the science, and how information like that is what’s preventing the average medical doctor to recommend HBOT for Cerebral Palsy.
di Girolamo and Dr. Harch urges viewers to find out for themselves if HBOT could be a good therapy for them or their loved one(s) living with CP. If you would like to dive into the world of Hyperbaric Oxygen Therapy for the treatment of Cerebral Palsy, HBOT News encourages you to find a licensed Hyperbaric Oxygen Therapy facility with hard mono-chambers or hard multi-place chambers, and act on this responsibly. Just like anything in the world of modern medicine, you can be injured or do more harm than good if HBOT is not administered correctly.
All of the data and success stories Dr. Harch reveals paints a much different picture than what the medical industry is showing us. Go try Hyperbaric Oxygen Therapy sooner than later to treat, heal, and ease the symptoms of Cerebral Palsy. We trust that HBOT can also change your life!
Subscribe Now, It’s Free !
Guest
Dr. Paul G. Harch, MD
Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.
Harch HBOT – Hyperbaric Oxygen Therapy Clinic
5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/
Recent HBOT News
International Survey Regarding the Use of Rehabilitation Modalities in Horses.
Abstract: To define which biologic, electrophysical and other modalities are used in horses for injury or performance issues, a questionnaire regarding 38 modalities was distributed to eight veterinary groups. A total of 305 complete or partial responses were obtained...
Clinical Trial – Effects of Repetitive Hyperbaric Oxygen Therapy in Patients With Acute Ischaemic Stroke
Background and Rationale:
Cerebrovascular disease is always ranked at the top causes of death and most of hospitalized
acute stroke patients have ischemic stroke [1].
Although the mortality rate of acute ischemic stroke is less than that of hemorrhagic stroke
[1], it still results in patient disabilities and complications that often lead to
significant costs to individuals, families, and society.
Traditional treatment for acute ischemic stroke includes thrombolytic therapy by injecting
tissue plasminogen activator (t-PA) within three hours after onset of symptoms [2],
antiplatelets and/or anticoagulant agents administered within the first 48 hours. Clinically,
the narrow time window of thrombolytic therapy and coexisting contraindications limit the use
of t-PA [2]. Thus, searching for an effective supplemental treatment for acute ischemic
stroke is imperative.
Hyperbaric oxygen therapy (HBOT) is valuable in treating acute carbon monoxide poisoning
[3,4], air or gas embolism [5], facilitating wound healing [6] and has been used as an
adjuvant treatment for many neurological disorders that need further study as concussion [7]
, stroke [8,9], cerebral palsy [ 10],traumatic brain injury [ 11], cerebral air embolism
[12], Autism [13] and multiple sclerosis [14].
Indications of hyperbaric oxygen therapy recommended by undersea and hyperbaric medical
society (UHMS) [15] are 1.air or gas embolism [5], 2.carbon monoxide poisoning [3,4],
3.clostridial myositis and myonecrosis [16], 4.crush injury, compartment syndrome and other
acute traumatic ischemias [17], 5.decompression sickness [18], 6.arterial insufficiencies
[19], 7.severe anemia [20], 8.intracranial abscess [21], 9.necrotizing soft tissue infections
[22],10. refractory osteomyelitis [23], 11.delayed radiation injury [24], 12.compromised
grafts and flaps [25], 13.acute thermal burn injury [26] and 14.idiopathic sudden
sensorineural hearing loss [27].
Known mechanisms of HBOT-induced neuroprotection include enhancing neuronal viability via
increased tissue oxygen delivery to the area of diminished blood flow, reducing brain edema,
and improving metabolism after ischemia [28,29]. Furthermore, a recent study performed on a
rat suggested that upregulation of the expression of glial derived neurotrophic factor (GDNF)
and nerve growth factor (NGF) might underlie the effect of HBOT [30].
The effectiveness of use of Hyperbaric oxygen therapy in human ischemic stroke is still
controversial that need further evaluation.
Clinical Trial – Effect of Adjuvant Hyperbaric Oxygen Therapy on Bells Palsy Outcome
This is a randomized, single blinded, non-placebo controlled that will compare one group of
Bells Palsy patients receiving the current standard of care including oral corticosteroids
and oral antivirals against an experimental group receiving the current standard of care in
addition to hyperbaric oxygen therapy. Outcome assessment will be based on both objective
analyses of facial movements as well as subjective quality of life scales.